Deucravacitinib Impurity 5
Specifications
Product name
Deucravacitinib Impurity 5
SRC CAT No
SRC-D3486
CAS No
2222717-56-6
Mol.F.
C10H10BrN3O
Mol.Wt.
268.1 g/mole
Related CAS No.
2829913-18-8 (HCl salt)
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
3-(3-Bromo-2-methoxyphenyl)-1-methyl-1H-1,2,4-triazole
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compound.Deucravacitinib is used to treat moderate to severe plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is given to patients who may receive other types of treatment, including pills, injection, or phototherapy (light treatment).
Deucravacitinib Impurity 5 CAS NO: 2222717-56-6 chemically represented as 3-(3-Bromo-2-methoxyphenyl)-1-methyl-1H-1,2,4-triazole.Synchemia is the leading manufacturing and exporter of Deucravacitinib Impurity 5.We supply Deucravacitinib Impurity 5 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Share your requirement and our team will take it forward with
clarity, confidentiality, and technical precision.
Related Products
Deucravacitinib
| CAT No | SRC-D3481 |
| CAS No | 1609392-27-9 |
| Mol.F. | C20H19D3N8O3 |
| Mol.Wt. | 425.5 g/mole |
| INV STATUS | In Stock |
Deucravacitinib Impurity 1
| CAT No | SRC-D3482 |
| CAS No | 1609394-05-9 |
| Mol.F. | C9H8N4O3 |
| Mol.Wt. | 220.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 2
| CAT No | SRC-D3483 |
| CAS No | 722538-98-9 |
| Mol.F. | C8H8N2O4 |
| Mol.Wt. | 196.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 3
| CAT No | SRC-D3484 |
| CAS No | 3026064-97-8 |
| Mol.F. | C9H10N2O3S |
| Mol.Wt. | 226.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 4
| CAT No | SRC-D3485 |
| CAS No | 3026064-99-0 |
| Mol.F. | C14H20N4O5 |
| Mol.Wt. | 324.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 6
| CAT No | SRC-D3487 |
| CAS No | 1609394-08-2 |
| Mol.F. | C10H10N4O3 |
| Mol.Wt. | 234.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 7
| CAT No | SRC-D3488 |
| CAS No | 1609393-48-7 |
| Mol.F. | C19H17D3N8O3 |
| Mol.Wt. | 411.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 8
| CAT No | SRC-D3489 |
| CAS No | NA |
| Mol.F. | C27H31D3N8O8 |
| Mol.Wt. | 601.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 9
| CAT No | SRC-D3490 |
| CAS No | NA |
| Mol.F. | C20H20D2N8O4 |
| Mol.Wt. | 440.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 10
| CAT No | SRC-D3491 |
| CAS No | 1609394-10-6 |
| Mol.F. | C10H12N4O |
| Mol.Wt. | 204.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 11
| CAT No | SRC-D3492 |
| CAS No | NA |
| Mol.F. | C5H3N2O4 : Na |
| Mol.Wt. | 155.1 : 23.0g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 12
| CAT No | SRC-D3493 |
| CAS No | 1609394-23-1 |
| Mol.F. | C16H13D3ClN7O2 |
| Mol.Wt. | 376.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 13
| CAT No | SRC-D3494 |
| CAS No | 2222717-51-1 |
| Mol.F. | C11H14N4O |
| Mol.Wt. | 218.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 14
| CAT No | SRC-D3495 |
| CAS No | 2948391-22-6 |
| Mol.F. | C11H14N4O |
| Mol.Wt. | 218.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 15
| CAT No | SRC-D3496 |
| CAS No | 121001-06-7 |
| Mol.F. | C8H6N2O3 |
| Mol.Wt. | 178.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 16
| CAT No | SRC-D3497 |
| CAS No | 2417137-50-7 |
| Mol.F. | C20H22N8O3 |
| Mol.Wt. | 422.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |